看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -3.6x - -4.0x | -3.8x |
| Historical Pb Multiple | -5.6x - -0.7x | -1.2x |
| Fair Value | $1.11 - $1.23 | $1.17 |
| Upside | -34.6% - -27.7% | -31.1% |
| Benchmarks | - | Full Ticker |
| Pro-Dex, Inc. | - | NasdaqCM:PDEX |
| Penumbra, Inc. | - | NYSE:PEN |
| ICU Medical, Inc. | - | NasdaqGS:ICUI |
| Escalon Medical Corp. | - | OTCPK:ESMC |
| TELA Bio, Inc. | - | NasdaqGM:TELA |
| SeaStar Medical Holding Corporation | - | NasdaqCM:ICU |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| PDEX | PEN | ICUI | ESMC | TELA | ICU | |||
| NasdaqCM:PDEX | NYSE:PEN | NasdaqGS:ICUI | OTCPK:ESMC | NasdaqGM:TELA | NasdaqCM:ICU | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -12.5% | -22.0% | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | -29.9% | 38.4% | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 124.6% | -84.6% | -296.9% | -89.9% | 18.9% | 5.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 12.6% | 1.5% | 1.7% | -1.2% | -108.7% | -31158.1% | ||
| Prior Fiscal Year | 15.3% | 8.6% | -1.3% | 1.8% | -79.8% | NA | ||
| Latest Fiscal Year | 4.0% | 1.2% | -4.9% | -1.5% | -54.6% | -18392.6% | ||
| Latest Twelve Months | 11.1% | 1.2% | -4.9% | 0.4% | -54.6% | -18392.6% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 23.5% | 1.8% | 1.2% | -15.6% | -203.4% | NA | ||
| Prior Fiscal Year | 24.8% | 8.4% | -1.4% | 20.9% | -281.2% | NM | ||
| Latest Twelve Months | 21.2% | 1.2% | -5.8% | 3.5% | -159.9% | NM | ||
| Next Fiscal Year | 24.7% | 12.2% | 8.4% | #NUM! | -236.1% | 178.1% | ||
| Two Fiscal Years Forward | 26.6% | 15.6% | 9.6% | -16.4% | 155.3% | 66.2% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 2.6x | 8.6x | 1.4x | 0.1x | 0.7x | 90.1x | ||
| Price / LTM EPS | 23.3x | 735.5x | -29.2x | 25.3x | -1.3x | -0.5x | ||
| Price / Book | 4.9x | 9.0x | 1.7x | 0.8x | 1.7x | -5.6x | ||
| Price / Fwd Book | 5.0x | 8.6x | 1.6x | 1.0x | -19.4x | -0.3x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.8x | 1.7x | 9.0x | |||||
| Historical P/B Ratio | -5.6x | -1.2x | -0.7x | |||||
| Selected P/B Multiple | -3.6x | -3.8x | -4.0x | |||||
| (x) Book Value | (2) | (2) | (2) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | PDEX | PEN | ICUI | ESMC | TELA | ICU | |
| Value of Common Equity | 157 | 10,305 | 3,437 | 1 | 49 | 12 | |
| (/) Shares Outstanding | 3.3 | 38.5 | 24.5 | 7.4 | 39.6 | 7.2 | |
| Implied Stock Price | 48.23 | 267.56 | 140.16 | 0.16 | 1.24 | 1.70 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 48.23 | 267.56 | 140.16 | 0.16 | 1.24 | 1.70 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |